GGrantIndex
Sort

51,593 grants matching hepatitis

Systemic delivery of an oncolytic adenovirus targeting TGFβ to enhance anti-PD-1 and anti-CTLA-4 therapy for triple negative breast cancer

$416,290
Weidong Xu · Endeavor Health Clinical Operations · R01 · FY2025 · CA

Leveraging arginase biology against metabolic disease

$416,258
Brian Jesse Debosch · Washington University · R01 · FY2024 · DK

Regulation of memory CD8 T cell development

$416,250
Susan M Kaech · Yale University · R37 · FY2017 · AI

Regulation of memory CD8 T cell development

$416,250
Susan M Kaech · Yale University · R37 · FY2014 · AI

Regulation of memory CD8 T cell development

$416,250
Susan M Kaech · Yale University · R37 · FY2016 · AI

Regulation of memory CD8 T cell development

$416,250
Susan M Kaech · Yale University · R37 · FY2015 · AI

Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH

$416,246
Michael Ohliger · University Of California, San Francisco · R01 · FY2019 · DK

Mechanisms of Regulation of Cannabinoid Disposition

$416,177
Nina Isoherranen · University Of Washington · P01 · FY2022 · DA

Understanding mechanism(s)that regulate liver growth and function

$416,093
Sayeepriyadarshini Anakk · University Of Illinois At Urbana-Champaign · R01 · FY2020 · DK

DNP-MRSI for the Detection of Latent, Treatment-Resistant Cellular Domains in HCC

$416,075
Terence P Gade · University Of Pennsylvania · R21 · FY2022 · CA

The Opposing Roles of IL-10 and IFN-gamma in Macrophage Activation Syndrome

$416,049
Edward M Behrens · Children'S Hosp Of Philadelphia · R01 · FY2016 · HL

Mechanisms of Regulation of Cannabinoid Disposition

$416,043
Nina Isoherranen · University Of Washington · P01 · FY2021 · DA

T Cells To AAV And AAV-Encoded Transgene Products

$416,035
Hildegund C. J. Ertl · Wistar Institute · P01 · FY2011 · HL

PPARgamma-regulated mechanisms in hepatocytes that promote NAFLD

$416,017
Jose Cordoba-Chacon · University Of Illinois At Chicago · R01 · FY2023 · DK

Development of Preventative and Therapeutic HCV Vaccines

$415,994
Vaccine Research Institute Of San Diego · R01 · FY2005 · AI

Animal Core

$415,984
Hidekazu Tsukamoto · University Of Southern California · P50 · FY2022 · AA

The Opposing Roles of IL-10 and IFN-gamma in Macrophage Activation Syndrome

$415,967
Edward M Behrens · Children'S Hosp Of Philadelphia · R01 · FY2017 · HL

Control of Lipogenesis and Hepatic Steatosis by Caspase-2

$415,961
Michael Karin · University Of California, San Diego · R01 · FY2019 · DK

The North Carolina Hepatitis Beta Clinical Research Network

$415,945
Michael W Fried · Univ Of North Carolina Chapel Hill · U01 · FY2009 · DK

Fatty Liver Disease and Hepatic Energy Homostatis in SH*

$415,935
Johns Hopkins University · R01 · FY2003 · DK

3/6 COMpAAAS U01: Intervention Study

$415,896
David Fiellin · Yale University · U01 · FY2017 · AA

Role of cytochrome P4501B1 in oxygen-mediated pulmonary injury

$415,885
Bhagavatula Moorthy · Baylor College Of Medicine · R01 · FY2014 · ES

PS11-001: National HIV Behavioral Surveillance, Los Angeles County

$415,867
Trista A. Bingham · Los Angeles County Public Health Department · U1B · FY2013 · PS

Ceramide and acute phase proteins elevation during aging

$415,845
Mariana Nikolova-Karakashian · University Of Kentucky · R01 · FY2022 · AG

Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH

$415,817
Michael Ohliger · University Of California, San Francisco · R01 · FY2020 · DK